365.1 Lymphoproliferative disease in kidney transplanted children: What has happened over three decades? A single center experience from Argentina.
Dr. Gabriela Gutièrrez, Argentina
365.2 The clinical efficacy and safety of Rituximab in pediatric kidney transplant recipients with refractory epstein-barr virus: A case-control study
Dr. Cemile Pehlivanoğlu, Turkey
365.3 Pediatric kidney transplantation with deceased donors: A 10-year pioneering experience of hypothermic machine perfusion in Latin America
Mrs. Petrúcia Maria A Pinheiro, Brazil
365.4 Exploring immune maturation in childhood transplantation: influence of age, organ type, thymus excision, and immunosuppression on lymphocyte populations
Miss Angela Hamie, Canada
365.5 Family Refusal Etiologies in organ donation among pediatric aged group, 17- year experiences
Dr. Arman Hasanzade, Iran
365.6 Mycophenolate mofetil (MMF) effect on anti-HLA donor-specific antibody (DSA) after pediatric living donor transplantation
Dr. Takehisa Ueno, Japan
365.7 Clinical features and longitudinal outcomes of COVID-19 in pediatric kidney transplant recipients: A large single-center experience from China
Dr. Qiang Zhang, People's Republic of China
365.8 Donor-derived fungal infections in transplant recipients: A case series and literature review of clinical characteristics and outcomes
Prof. Esra Baskin, Turkey
365.9 Fluid management during pediatric lung transplantation: single-center experience
Lifang Zhang, People's Republic of China
365.10 Assessing readiness for transition among adolescent and young adult kidney transplant recipients
Ms. Leandra Bitterfeld, United States
365.11 Pediatric kidney transplantation in Dubai. Outcomes and challenges
Dr. Marwa Mohamed, United States
365.12 Nalbuphine postoperative analgesia for pediatric renal transplantation surgery. A case series report